Similarly, dickkopf-1 protein (DKK1) can serve as a biomarker of HCC, contributing to the identification of patients with AFP-negative HCC and acting as an inhibitor of Wnt/β-catenin signaling [168]. This evidence concerns the gene AFP and hepatocellular carcinoma.